C
Interleukin-6 (IL-6)
Inflammatory & ImmuneLab test / biomarkerriskpartially modifiable
11
evidence score
Also known as: IL-6, interleukin (IL)-6, interleukin-6
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 6meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (3)
0 meta-analyses / systematic reviews- Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. — Cardiology in review 2014 · PMID 24618929
- Current update on HIV-associated vascular disease and endothelial dysfunction. — World journal of surgery 2007 · PMID 17372667
- Alcohol consumption, cardiovascular health, and endothelial function markers. — Alcohol (Fayetteville, N.Y.) 2007 · PMID 17980786
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT03377465 | Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis | COMPLETED | INTERVENTIONAL | ADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin |
| NCT05612269 | SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study | UNKNOWN | OBSERVATIONAL | interleukin 6 |
Genetic associations (0)
None linked.